Area of research
Toxicology · Geriatrics and Gerontology
Research interest
Research interests include Medicine, Internal medicine, Population, Coronavirus disease 2019 (COVID-19), First line, and Observational study.
Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes
Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease‐modifying antirheumatic drugs: A multi‐centre cohort study
Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty
Estimating incidence rates of periprosthetic joint infection after hip and knee arthroplasty for osteoarthritis using linked registry and administrative health data
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients
Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases
Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies
Characterizing treatment pathways at scale using the OHDSI network
The Asian Pharmacoepidemiology Network (AsPEN): promoting multi‐national collaboration for pharmacoepidemiologic research in Asia